{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:27:12Z","timestamp":1759580832612},"reference-count":33,"publisher":"University of Tokushima Faculty of Medicine","issue":"3.4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2152\/jmi.63.192","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T22:08:21Z","timestamp":1474063701000},"page":"192-198","source":"Crossref","is-referenced-by-count":3,"title":["Thirty percent of ductal carcinoma in situ of the breast in Japan is extremely low-grade ER(+)\/HER2(-) type without comedo necrosis"],"prefix":"10.2152","volume":"63","author":[{"given":"Miyuki","family":"Kanematsu","sequence":"first","affiliation":[{"name":"Department of Surgery, Shikoku Medical Center for Children and Adults"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, the University of Tokushima Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokushima Breast Care Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Higashi Tokushima Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Bando","sequence":"additional","affiliation":[{"name":"Division of Pathology, Tokushima University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Moriya","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Tadokoro","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, the University of Tokushima Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misako","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, the University of Tokushima Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Takechi","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, the University of Tokushima Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, the University of Tokushima Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Toba","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, the University of Tokushima Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuteru","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, the University of Tokushima Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiichiro","family":"Kajikawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Shikoku Medical Center for Children and Adults"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tangoku","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, the University of Tokushima Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Imoto","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Institute of Health Biosciences, the University of Tokushima Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunori","family":"Sasa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokushima Breast Care Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bleyer A, Welch HG: Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med: 1998-2005, 2012","DOI":"10.1056\/NEJMoa1206809"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ: Effect of screening and adjuvant therapy on mortality from breast cancer. Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. N Engl J Med 353: 1784-92, 2005","DOI":"10.1056\/NEJMoa050518"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. G\u00f8tzsche PC, Nielsen M: Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD001877. doi: 10. 1002\/14651858. CD001877. pub5","DOI":"10.1002\/14651858.CD001877.pub5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Miller AB, To T, Baines CJ, Wall C: The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 137: 305-12, 2002","DOI":"10.7326\/0003-4819-137-5_Part_1-200209030-00005"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA: Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348: g366, 2014","DOI":"10.1136\/bmj.g366"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. The Independent UK Panel on Breast Cancer Screening: Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. The Lancet 380: 1778-86, 2012","DOI":"10.1016\/S0140-6736(12)61611-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Suzuki A, Ishida T, Ohuchi N: Controversies in breast cancer screening for women aged 40-49 years. Jpn J Clin Oncol 44: 613-8, 2014","DOI":"10.1093\/jjco\/hyu054"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Puliti D, Miccinesi G, Paci E: Overdiagnosis in breast cancer: design and methods of estimation in observational studies. Prev Med (Baltim) 53: 131-3, 2011","DOI":"10.1016\/j.ypmed.2011.05.012"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. U.S. Preventive Services Task Force<sup>*<\/sup>: Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 151: 716-26, 2009","DOI":"10.7326\/0003-4819-151-10-200911170-00008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rosen PP, Braun DW Jr, Kinne DE: The clinical significance of pre-invasive breast carcinoma. Cancer 15: 919-25, 1980","DOI":"10.1002\/1097-0142(19800815)46:4+<919::AID-CNCR2820461311>3.0.CO;2-Z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Vilaprinyo E, Forn\u00e9 C, Carles M, Sala M, Pla R, Castells X, Domingo L, Rue M; Interval Cancer (INCA) Study Group: Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer. PLoS One 9: e86858. doi: 10. 1371\/journal. pone. 0086858. e Collection 2014","DOI":"10.1371\/journal.pone.0086858"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sue GR, Lannin DR, Killelea B, Chagpar AB: Predictors of microinvasion and its prognostic role in ductal carcinoma in situ. Am J Surg 206: 478-81, 2013","DOI":"10.1016\/j.amjsurg.2013.01.039"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M: 259 Patients with DCIS of the breast applying USC\/Van Nuys prognostic index: a retrospective review with long term follow up. Breast Cancer Res Treat 109: 405-16, 2008, Epub 2007 Aug 9. Review.","DOI":"10.1007\/s10549-007-9668-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tsikitis VL, Chung MA: Biology of ductal carcinoma in situ classification based on biologic potential. Am J Clin Oncol 29: 305-10, 2006","DOI":"10.1097\/01.coc.0000198740.33617.2f"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wiechmann L, Kuerer HM: The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 112: 2130-42, 2008","DOI":"10.1002\/cncr.23430"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tang P, Hajdu SI, Lyman GH: Ductal carcinoma in situ: a review of recent advances. Curr Opin Obstet Gynecol 19: 63-7, 2007","DOI":"10.1097\/GCO.0b013e3280114a3a"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lari SA, Kuerer HM: Biological markers in DCIS and risk of breast recurrence: A systematic review. J Cancer 2: 232-61, 2011","DOI":"10.7150\/jca.2.232"},{"key":"18","unstructured":"18. Seth A, Kitching R, Landberg G, Xu J, Zubovits J, Burger AM: Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. Anticancer Res 23: 2043-51, 2003"},{"key":"19","unstructured":"19. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B: Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 11: 167-80, 1994"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, Land SR, Margolese RG, Swain SM, Costantino JP, Wolmark N: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103: 478-88, 2011","DOI":"10.1093\/jnci\/djr027"},{"key":"21","unstructured":"21. Habel LA, Daling JR, Newcomb PA, Self SG, Porter PL, Stanford JL, Seidel K, Weiss NS: Risk of recurrence after ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 7: 689-96, 1998"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Wang SY, Shamliyan T, Virnig BA, Kane R: Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat 127: 1-14, 2011","DOI":"10.1007\/s10549-011-1387-4"},{"key":"23","unstructured":"23. Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11: 155-68, 1998"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Meijnen P, Peterse JL, Antonini N, Rutgers EJ, van de Vijver MJ: Immunohistochemical categorisation of ductal carcinoma in situ of the breast. Br J Cancer 98: 137-42, 2008","DOI":"10.1038\/sj.bjc.6604112"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, Sanchez H, Jimenez C, Stewart K, Chew K, Ljung BM, Tlsty TD: Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 102: 627-37, 2010","DOI":"10.1093\/jnci\/djq101"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Gauthier ML, Berman HK, Miller C, Kozakeiwicz K, Chew K, Moore D, Rabban J, Chen YY, Kerlikowske K, Tlsty TD: Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell 12: 479-91, 2007","DOI":"10.1016\/j.ccr.2007.10.017"},{"key":"27","unstructured":"27. Williams KE, <i>et al<\/i>. 35<sup>th<\/sup> Annual San Antonio Breast Cancer Symposium; San Antonio, 2012"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Rakovitch E, Nofech-Mozes S, Hanna W, Narod S, Thiruchelvam D, Saskin R, Spayne J, Taylor C, Paszat L: HER2\/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 106: 1160-5, 2012","DOI":"10.1038\/bjc.2012.41"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL: Efficacy of screening mammography-a metaanalysis-. JAMA 273: 149-54, 1995","DOI":"10.1001\/jama.1995.03520260071035"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Meijnen P, Peterse JL, Antonini N, Rutgers EJ, van de Vijver MJ: Immunohistochemical categorisation of ductal carcinoma in situ of the breast. Br J Cancer 98: 137-42, 2008","DOI":"10.1038\/sj.bjc.6604112"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Flowers CI, O&apos;Donoghue C, Moore D, Goss A, Kim D, Kim JH, Elias SG, Fridland J, Esserman LJ: Reducing false-positive biopsies: A pilot study to reduce benign biopsy rates for BI-RADS 4A\/B assessments through testing risk stratification and new thresholds for intervention. Breast Cancer Res Treat 139: 769-77, 2013","DOI":"10.1007\/s10549-013-2576-0"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Etzioni R, Gulati R, Mallinger L, Mandelblatt J: Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med 158: 831-8, 2013","DOI":"10.7326\/0003-4819-158-11-201306040-00008"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wells CJ, O&apos;Donoghue C, Ojeda-Fournier H, Retallack HE, Esserman LJ: Evolving paradigm for imaging, diagnosis, and management of DCIS. J Am Coll Radiol 10: 918-23, 2013","DOI":"10.1016\/j.jacr.2013.09.011"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/63\/3.4\/63_192\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T04:43:39Z","timestamp":1692506619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/63\/3.4\/63_192\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":33,"journal-issue":{"issue":"3.4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.63.192","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}